Literature DB >> 22089257

[The medical management of high risk individuals. Experiences with persons exposed to chronic internal irradiation].

G van Kaick1, S Delorme.   

Abstract

The medical management and counseling of persons at high risk due to exposure to chemicals or radiation or due to personal disposition, present an additional challenge for physicians and especially radiologists involved. This article is based on own experiences with patients who had been exposed to Thorotrast. They had been injected with the contrast medium Thorotrast, which was in use world-wide until around 1950. Thorotrast caused a chronic alpha irradiation mainly of the liver (up to 0.4 Gy/a), spleen (1.2 Gy/a) and bone marrow (0.1 Gy/a). For the Thorotrast patients and their physicians the most worrying problem was the risk of primary malignant liver tumors which occurred in more than 20% of the exposed persons, i.e. 100 times more frequently than in a non-exposed control group. The medical and especially radiological experiences with the management of these patients summarize a general aspect of the problem and can be referred to when managing other high risk groups.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22089257     DOI: 10.1007/s00117-011-2250-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  11 in total

1.  Effect of gamma radiation on native endolithic microorganisms from a radioactive waste deposit site.

Authors:  B J Pitonzo; P S Amy; M Rudin
Journal:  Radiat Res       Date:  1999-07       Impact factor: 2.841

Review 2.  [Screening from an epidemiologic perspective].

Authors:  N Becker
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

3.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.

Authors:  Christiane K Kuhl; Simone Schrading; Claudia C Leutner; Nuschin Morakkabati-Spitz; Eva Wardelmann; Rolf Fimmers; Walther Kuhn; Hans H Schild
Journal:  J Clin Oncol       Date:  2005-11-20       Impact factor: 44.544

4.  Locoregional late effects of paravascular thorotrast deposits: results of the german thorotrast study.

Authors:  H P Schlemmer; D Liebermann; V Naser; G Van Kaick
Journal:  J Neuroradiol       Date:  2000-12       Impact factor: 3.447

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  [Thorotrast-induced liver cancer: results of the German thorotrast study].

Authors:  G van Kaick; M L Bahner; D Liebermann; H Lührs; H Wesch
Journal:  Radiologe       Date:  1999-08       Impact factor: 0.635

Review 7.  [New information on high risk breast screening].

Authors:  C C Riedl; L Ponhold; R Gruber; K Pinker; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

Review 8.  [Therapy-induced effects in normal tissue].

Authors:  G van Kaick; S Delorme
Journal:  Radiologe       Date:  2008-09       Impact factor: 0.635

9.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-14       Impact factor: 91.245

10.  I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident.

Authors:  Alina V Brenner; Mykola D Tronko; Maureen Hatch; Tetyana I Bogdanova; Valery A Oliynik; Jay H Lubin; Lydia B Zablotska; Valery P Tereschenko; Robert J McConnell; Galina A Zamotaeva; Patrick O'Kane; Andre C Bouville; Ludmila V Chaykovskaya; Ellen Greenebaum; Ihor P Paster; Victor M Shpak; Elaine Ron
Journal:  Environ Health Perspect       Date:  2011-03-17       Impact factor: 9.031

View more
  1 in total

1.  [Retention of contrast media in the history of radiology : Sequelae of the former use of thorotrast and new challenges].

Authors:  G van Kaick; S Delorme
Journal:  Radiologe       Date:  2016-12       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.